Detalhe da pesquisa
1.
p3k14c, a synthetic global database of archaeological radiocarbon dates.
Sci Data
; 9(1): 27, 2022 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35087092
2.
Patient-reported outcomes in a phase iii study of everolimus versus placebo in patients with metastatic carcinoma of the kidney that has progressed on vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy.
Oncologist
; 16(5): 632-40, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21459902
3.
Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma.
Am J Respir Crit Care Med
; 182(3): 396-403, 2010 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20194812
4.
Mapping past human land use using archaeological data: A new classification for global land use synthesis and data harmonization.
PLoS One
; 16(4): e0246662, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33852578
5.
Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.
Lancet
; 372(9637): 449-56, 2008 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-18653228
6.
Archaeological assessment reveals Earth's early transformation through land use.
Science
; 365(6456): 897-902, 2019 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31467217
7.
Of cattle and feasts: Multi-isotope investigation of animal husbandry and communal feasting at Neolithic Makriyalos, northern Greece.
PLoS One
; 13(6): e0194474, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29879125
8.
Mapping our reliance on the tropics can reveal the roots of the Anthropocene.
Nat Ecol Evol
; 7(5): 632-636, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36823256
9.
Phase I study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PTK787/ZK 222584 administered twice daily in patients with advanced cancer.
J Clin Oncol
; 23(18): 4162-71, 2005 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15867205
10.
Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial.
J Clin Oncol
; 23(13): 2946-54, 2005 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15699477
11.
Body mass index, airflow obstruction and dyspnea and body mass index, airflow obstruction, dyspnea scores, age and pack years-predictive properties of new multidimensional prognostic indices of chronic obstructive pulmonary disease in primary care.
Ann Thorac Med
; 11(4): 261-268, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27803752
12.
Guidelines and the diagnosis of COPD.
Am J Respir Crit Care Med
; 179(8): 734, 2009 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19351874
13.
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
JAMA
; 290(16): 2149-58, 2003 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-14570950
14.
Population pharmacokinetic/pharmacodynamic modeling to assist dosing schedule selection for dovitinib.
J Clin Pharmacol
; 53(1): 14-20, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23400739
15.
Phase I study of dovitinib (TKI258), an oral FGFR, VEGFR, and PDGFR inhibitor, in advanced or metastatic renal cell carcinoma.
Clin Cancer Res
; 19(5): 1257-68, 2013 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23339124
16.
Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.
Clin Cancer Res
; 19(13): 3693-702, 2013 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23658459
17.
Precision in Diagnosing and Classifying COPD: Comparison of Historical Height with Current Height and Arm Span to Predict FEV(1).
Open Respir Med J
; 6: 54-8, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22896775
18.
Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.
Cancer
; 116(18): 4256-65, 2010 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20549832
19.
Progression-free survival: gaining on overall survival as a gold standard and accelerating drug development.
Cancer J
; 15(5): 386-94, 2009.
Artigo
em Inglês
| MEDLINE | ID: mdl-19826358
20.
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy.
J Hematol Oncol
; 2: 45, 2009 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-19860903